Delivery Order SPE2DB25D3402-SPE2DB26FUFWZ
- Not listed
- The Defense Logistics Agency awarded a $10,868.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 ml auto-injectors. This non-set-aside contract was awarded on October 28, 2025, with an ultimate completion date of October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector units. This firm fixed-price delivery order, valued at $6,863.64, represents a competitive award with no set-aside designation and is scheduled for completion by August 21, 2025. The award was issued to AmerisourceBergen's Corporate Office division, with performance to take place at the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,718.32 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens on August 6, 2025, with completion due by August 7, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued...
- The Defense Logistics Agency awarded a $2,287.88 delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Actemra Actpen 162 mg/0.9 ml auto-injector pens. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order does not utilize a set-aside designation. This delivery order operates under...
- The Defense Logistics Agency awarded a $4,430.83 firm fixed-price delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. The contract specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 24, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $19,253.01 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. The contract, executed on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. Performance will be conducted at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $8,507.45 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 ml auto-injectors. This firm fixed price, non-competitive delivery order is scheduled for completion by September 29, 2025, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,575.76 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. This firm fixed-price delivery order, issued on August 29, 2025, is set to be completed by September 2, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract was competitively awarded without set-aside restrictions, reflecting the contractor's demonstrated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,058.52 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL injectable medication. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this firm fixed-price contract requires performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The Defense Logistics Agency awarded a delivery order valued at $5,967.40 to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 ml pharmaceutical product on August 6, 2025, with an ultimate completion date of August 7, 2025. The contract is a firm fixed price delivery order with no set-aside designation, and performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- SPE2DB25D3402Indefinite Delivery Contract
- SPE2DB25D3402-SPE2DB26FUFWZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,983.88 to AmerisourceBergen Drug Corp for the supply of Actemra Actpen 162 mg/0.9 mL injections. This firm fixed price, competitively awarded delivery order was issued on November 4, 2025, with an ultimate completion date of November 5, 2025. The contract represents a pharmaceutical procurement to support federal medical supply needs, with performance to be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion master contract running through December 2026 that serves as a comprehensive pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains extensive product portfolios including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The company's federal contract awards demonstrate consistent capability to fulfill competitive procurements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract vehicles designed to support global military medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/4/25 |